Search

Your search keyword '"Murray, James B."' showing total 176 results

Search Constraints

Start Over You searched for: Author "Murray, James B." Remove constraint Author: "Murray, James B."
176 results on '"Murray, James B."'

Search Results

1. Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo Activity.

5. A Helical Twist-induced Conformational Switch Activates Cleavage in the Hammerhead Ribozyme

6. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction11Edited by J. Doudna

8. Capture and Visualization of a Catalytic RNA Enzyme-Product Complex Using Crystal Lattice Trapping and X-Ray Holographic Reconstruction

9. Does a single metal ion bridge the A-9 and scissile phosphate groups in the catalytically active hammerhead ribozyme structure?11Edited by J. Karn

10. The hammerhead, hairpin and VS ribozymes are catalytically proficient in monovalent cations alone

13. PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discovery

14. The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its Analogues

15. Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B

16. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

17. A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinaseElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3md00439b

20. The structural basis of hammerhead ribozyme self-cleavage

23. Crystal structure of an RNA bacteriophage coat protein-operator complex

24. Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1

25. PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discoveryElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d2md00197g

27. Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)

28. Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase

29. The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography

30. Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)

31. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction.

36. Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity

37. Corrigendum to “Structure-guided design of α-amino acid-derived Pin1 inhibitors” [Bioorg. Med. Chem. Lett. 20 (2010) 586]

38. Abstract 4432: Discovery of novel Pin1 inhibitors by structure-guided fragment evolution that downregulate cyclin D1 expression in PC-3 prostate cancer cells

39. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

40. Abstract A212: A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor‐induced apoptosis in HCT116 colon carcinoma cells

41. Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design

42. Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping

43. Letters.

45. Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR

49. Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2

Catalog

Books, media, physical & digital resources